chronic lung disease Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Phase 3 (1)

Interventional (2)

Erasmus Medical Center (1)
Johns Hopkins University (1)

No (2)

No (2)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadapnea

I am/have/hadlung disease

I am/have/hadoff-label

I am/have/hadnervous

I am/have/hadmycobacterium avium complex

I am/have/hadmechanical ventilation

I am/have/hadmycobacterium avium complex infection

I am/have/hadpulmonary disease

I am/have/hadcontinuous positive airway pressure

I am/have/hadmycobacterial infections

I am/have/hadmycobacterium avium-intracellulare infection

added new label for I am/have/had

more

I am looking for

I am looking forazithromycin

I am looking forazithormycin

I am looking fordoxapram

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 3
For pediatric ages
Recruiting in 100s
Interventional Study
all
Respiratory Diseases
Recruiting

Doxapram Therapy in Preterm Infants (DOXA Trial)

Although this will result in complete resolution of AOP, invasive mechanical ventilation has the disadvantage of being a major risk of chronic lung disease and impaired neurodevelopmental outcome. Restrictive invasive ventilation is therefore advocated nowadays in preterm infants.

apnea

lung disease

off-label

doxapram

nervous

0 views
16 Feb, 2024
18 locations

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hepatology
Recruiting

Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study

To assess the early bactericidal activity of Azithromycin 250mg by mouth daily over the first 14 days of treatment for Mycobacterium avium complex (MAC) lung disease.

azithromycin

lung disease

mycobacterium avium complex

mycobacterium avium complex infection

azithormycin

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.